Bristol-Myers Squibb recalled 12,778 Opdualag single-dose vials nationwide after a lack of assurance of sterility was identified. The product is nivolumab and relatlimab-rmbw injection. The recall date is 2025-10-21. Healthcare providers should stop using affected lots and follow the recall letter guidance.
Lack of Assurance of Sterility.
Consumers and healthcare providers should stop using this product immediately. Contact Bristol-Myers Squibb Company or your healthcare provider for guidance. Notification method: Letter
Get instant alerts for Health & Personal Care recalls
Be the first to know. Free instant alerts to your inbox.
Opdualag is a prescription cancer immunotherapy consisting of nivolumab and relatlimab-rmbw. It is administered via intravenous injection and is distributed through healthcare channels to patients under medical supervision.
The product was recalled due to lack of assurance of sterility, which could lead to contamination and infection risks if administered.
This recall is not stated as part of a broader industry pattern.
Hospitals and clinics must identify affected lots, quarantine vials, and follow recall guidance. The issue could impact patient safety and supplies in oncology treatment settings.
FDA recall page and manufacturer communications; official recall letter
Recall communications will be issued to healthcare providers; replacement or guidance timelines will be provided by the manufacturer and FDA
Keep recall letters, lot numbers, NDC, expiry dates, and correspondence with the manufacturer for records
Brand: Opdualag Generic: nivolumab and relatlimab-rmbw NDC: 0003-7125-11 Pack: Single Dose Vial, Rx Only Manufacturer: Bristol-Myers Squibb Company, Princeton, NJ 08543 Quantity recalled: 12,778 vials Lot: 033A23B Expiry: 04/30/2026 Sold nationwide in the USA Recall date: 2025-10-21 Status: Active Reason: Lack of Assurance of Sterility Notes: Distribution nationwide; Rx only; 12,778 total vials with Lot 033A23B
No injuries or incidents have been reported.
Not sure what to do next? Our guide walks you through the process step by step.
Read: What to Do When You Find a Recalled ProductGet instant alerts for recalls that affect you. Free forever.
AvKARE recalled 7,991 cartons of Rosuvastatin Tablets on December 31, 2025. The recall stems from the product being out of specification for dissolution. Consumers should stop using the medication immediately and consult healthcare providers for guidance.
ZOLIQUEX recalled adult portable bed rails sold on Amazon after reports of entrapment and asphyxiation risk. The recall targets silver bed rails measuring 12.4 inches wide by 33.07 inches tall and weighing 7.1 pounds. The model numbers ZEX014-V1 and the Zoliquex branding appear on packaging. Stop using the product and seek a full refund by contacting ZOLIQUEX.
Vitaquest International recalled Arey Not Today iron supplements sold at retailers nationwide after determining the products do not meet the Poison Prevention Packaging Act's child-resistant packaging requirement. The noncompliant packaging creates a poisoning risk to young children if ingested. Consumers should stop using the products immediately and contact Vitaquest for a free child-resistant替换
Easymake adult portable bed rails imported by ZFZG-US are recalled on April 9, 2026. The recall cites a risk of entrapment and asphyxiation and notes the product lacks required hazard warning labels. Stop using the recalled rails immediately and contact ZFZG-US for a full refund.
Taro Pharmaceuticals announced a market withdrawal of Diclofenac Sodium, Topical Gel, 3% on January 27, 2026. The withdrawal stems from out of specification viscosity results. Healthcare providers and consumers should stop using the product immediately.
Sangohe expands its 2026 recall of adult portable bed rails 504E and 504Q due to entrapment and asphyxiation risk. The recall cites noncompliance with the mandatory standard and missing warning labels. Stop using the recalled rails and pursue a full refund by contacting Sangohe.
Tuymec Minoxidil Hair Growth Kit sold on Amazon by DrHealBeauty is recalled for non-child-resistant packaging. The kit contains two black spray bottles with 5% minoxidil and BIOTIN labels. Consumers should stop using the product immediately and contact DrHealBeauty for a free empty replacement bottle with a child-resistant closure.
TecFlox recalled its Minoxidil Topical Solution hair growth serum bottles on April 2, 2026. The packaging is not child-resistant, violating the Poison Prevention Packaging Act. Consumers should stop using the product immediately, store it out of reach of children, and email TecFloxrecall@outlook.com to receive free replacement bottles. Only bottles with serum remaining will be replaced; dispose of